NCT00165295
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.
NCT00165295
NCT00142129
NCT00142155
NCT00004107
NCT00561743
Not specified
NCT01010880
NCT01370434
NCT00270101
Not specified
NCT00270166
Not specified
NCT00752518
Not specified